The $3.05B acquisition of Halda Therapeutics expands Johnson & Johnson's oncology pipeline in prostate cancer and solid tumor ...

In this sector, news comes from research — on hair loss, smoking cessation, lupus, gonorrhea — and mergers and acquisitions.

This year, two Dividend Kings, companies with decades-long track records of increasing payouts, have not only delivered ...